Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Small-Cap Biotech Spikes 50% On P&G Deal
Small-Cap Biotech Spikes 50% On P&G Deal
Small-Cap Biotech Spikes 50% On P&G Deal
Submitted by
admin
on August 25, 2010 - 12:26pm
Source:
Yahoo/IndieResearch
News Tags:
P&G
Somaxon
Amarin
Repros Therapeutics
Chelsea Therapeutics
Amicus Therapeutics
Headline:
Small-Cap Biotech Spikes 50% On P&G Deal
Do Not Allow Advertisers to Use My Personal information
